| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
S87785-1mg买3赠1 |
99.60% | ￥180.00 |
9 | - | - | - | - |
|
S87785-5mg买3赠1 |
99.60% | ￥220.00 |
6 | - | - | - | - |
|
S87785-10mg促销 |
99.60% | ￥310.00 ￥248.00 |
6 | - | - | - | - |
|
S87785-25mg促销 |
99.60% | ￥410.00 ￥328.00 |
6 | - | - | - | - |
|
S87785-50mg |
≥98% | ￥550.00 |
货期：2-3天 | - | - | - | - |
|
S87785-100mg |
≥98% | ￥740.00 |
货期：2-3天 | - | - | - | - |
|
| 产品描述： | VU0155041 is a potent, selective positive allosteric modulator (PAM) of mGluR4, with EC50s of 798 nM and 693 nM for human and rat mGluR4, respectively. VU0155041 has potential for the research of Parkinson's disease (PD) | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶点： | Human mGlu4:798 nM (EC50);Rat mGlu4:693 nM (EC50);GluR | ||||||||||||||||||||
| 体内研究： | VU0155041 (31 nmol, 93 nmol; i.c.v.) reverses catalepsy induced by the dopamine D2 receptor antagonist Haloperidol (1.5 mg/kg, i.p.) in rats[1].VU0155041 (93 nnmol, 316 nmol; i.c.v.) reverses Reserpine (HY-N0480)-induced akinesia in rats. Animal Model: Third ventricle cannulated (TVC) Male Sprague-Dawley rats (225-255 g) Dosage: 31 nmol, 93 nmol (10 μL) Administration: Intracerebroventrical injection, after the Haloperidol (1.5 mg/kg) treatment 2 hours Result: Decreased the cataleptic effects of Haloperidol, and the effects still presented 30 min after infusion. | ||||||||||||||||||||
| 参考文献： | 1. Niswender CM, et, al. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4. Mol Pharmacol. 2008 Nov; 74(5): 1345-58. | ||||||||||||||||||||
| 溶解性： | Soluble in DMSO | ||||||||||||||||||||
| 保存条件： | -20℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京